Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro

Molecular Biology Reports

Volumn 37, Issue 6, 2010, Pages 2579-2586

  Zhang, Lin ^a   Huang, Haili ^a   Wu, Kai ^a   Wang, Mengwei ^a   Wu, Benyan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

BTG2 gene; Cell apoptosis; Cell cycle; Gastric cancer

Indexed keywords

B LYMPHOCYTE TRANSLOCATION PROTEIN 2; COMPLEMENTARY DNA; LIPOSOME; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BTG2 PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CELL COUNT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DRUG TARGETING; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS POTENTIAL; PHENOTYPE; STOMACH CANCER; CELL MOTION; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSFECTION; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEINS;

EID: 77955661930     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-009-9777-y     Document Type: Article

References (25)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 10.3322/canjclin.55.2.74 15761078
2. KD Crew AI Neugut 2006 Epidemiology of gastric cancer World J Gastroenterol 12 354 362 16489633
3. HJ Stein A Sendler U Fink JR Siewert 2000 Multidisciplinary approach to esophageal and gastric cancer Surg Clin North Am 80 659 682 10.1016/S0039- 6109(05)70205-X 10.1016/S0039-6109(05)70205-X 1:STN:280:DC%2BD3c3psFOiug%3D%3D 10836011
4. N Ikematsu, et al. 1999 Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases Oncogene 18 7432 7441 10.1038/sj.onc.1203193 10.1038/sj.onc.1203193 1:CAS:528:DC%2BD3cXpslWn 10602502
5. P Buanne, et al. 2000 Cloning of PC3B, a novel member of the PC3/BTG/TOB family of growth inhibitory genes, highly expressed in the olfactory epithelium Genomics 68 253 263 10.1006/geno.2000.6288 10.1006/geno.2000.6288 1:CAS:528:DC%2BD3cXmsFKlsLs%3D 10995567
6. S Matsuda J Rouault J Magaud C Berthet 2001 In search of a function for the Tis21/PC3/BTG1/TOB family FEBS Lett 497 67 72 10.1016/S0014-5793(01)02436-X 10.1016/S0014-5793(01)02436-X 1:CAS:528:DC%2BD3MXjslent7c%3D 11377414 (Pubitemid 32476878)
7. F Guchenneux, et al. 1997 Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle Leukemia 11 370 375 10.1038/sj.leu.2400599 10.1038/sj.leu.2400599
8. T Felice 2001 The gene PC3TIS21/BTG2, prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol 187 155 165 10.1002/jcp.1062 10.1002/jcp.1062 (Pubitemid 32270074)
9. VP Sukhatme S Kartha FG Toback R Taub RG Hoover CH Tsaimorris 1987 A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens Oncogene Res 1 343 355 1:STN:280:DyaL1c3hslegsw%3D%3D 3130602
10. BS Fletcher RW Lim BC Varnum DA Kujubu RA Koski HR Herschman 1991 Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters J Biol Chem 266 14511 14518 1:CAS:528: DyaK38XisV2ltb8%3D 1713584
11. C Duriez N Falette C Audoynaud C Moyret-Lalle K Bensaad S Courtois Q Wang T Soussi A Puisieux 2002 The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene Gene 282 207 214 10.1016/S0378-1119(01)00825-3 10.1016/S0378-1119(01)00825-3 1:CAS:528:DC%2BD38XnvFSntw%3D%3D 11814693 (Pubitemid 34117577)
12. IK Lim MS Lee SH Lee NK Kim I Jou JS Seo SC Park 1995 Differential expression of TIS21 and TIS1 genes in the various organs of Balb/c mice, thymic carcinoma tissues and human cancer cell lines J Cancer Res Clin Oncol 121 279 2848 10.1007/BF01209594 10.1007/BF01209594 1:CAS:528:DyaK2MXnt1Okurs%3D 7768965
13. K Struckmann P Schraml R Simon K Elmenhorst M Mirlacher J Kononen H Moch 2004 Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma Cancer Res 64 1632 1638 10.1158/0008-5472.CAN-03-1687 10.1158/0008-5472.CAN-03-1687 1:CAS:528:DC%2BD2cXhslektbg%3D 14996721 (Pubitemid 38428683)
14. MA Ficazzola M Fraiman J Gitlin K Woo J Melamed MA Rubin PD Walden 2001 Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis Carcinogenesis 22 1271 1279 10.1093/carcin/22.8.1271 10.1093/carcin/22.8.1271 1:CAS:528:DC%2BD3MXlvVSqu7w%3D 11470758
15. Y Wang C Shao CH Shi L Zhang HH Yue PF Wang B Yang YT Zhang F Liu WJ Qin H Wang GX Shao 2005 Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism Asian J Androl 7 375 380 10.1111/j.1745-7262.2005.00031.x 10.1111/j.1745-7262.2005.00031.x 1:CAS:528:DC%2BD28XktVyitw%3D%3D 16281084 (Pubitemid 41819351)
16. Y Shaobo W Mengwei S Yong Y Weidi W Weihua 2004 Screening differentially expressed genes of gastric adenocarcinoma by cDNA microarray China J Cancer Prev Treat 11 117 120
17. Y Shao SB Yang MW Wang BY Wu WD You H Li 2004 Gene expression profile of human adenocarcinoma by cDNA microarray and clustering Chin J Med Genet 21 110 115 1:CAS:528:DC%2BD2cXptlOqsbY%3D
18. S Farioli-Vecchioli M Tanori L Micheli M Mancuso L Leonardi A Saran MT Ciotti E Ferretti A Gulino S Pazzaglia F Tirone 2007 Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3 FASEB J 21 2215 2225 10.1096/fj.06-7548com 10.1096/fj.06-7548com 1:CAS:528:DC%2BD2sXnvVagtrY%3D 17371797 (Pubitemid 47026456)
19. IK Lim 2006 TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule J Cancer Res Clin Oncol 132 417 426 10.1007/s00432-006-0080-1 10.1007/s00432-006-0080-1 1:CAS:528: DC%2BD28Xks1emtbw%3D 16456675
20. H Kawakubo E Brachtel T Hayashida G Yeo J Kish A Muzikansky PD Walden S Maheswaran 2006 Loss of B-cell translocation gene-2 in estrogen receptor-positive breast carcinoma is associated with tumor grade and overexpression of cyclin d1 protein Cancer Res 66 7075 7082 10.1158/0008-5472. CAN-06-0379 10.1158/0008-5472.CAN-06-0379 1:CAS:528:DC%2BD28XmvFGkt7w%3D 16849553 (Pubitemid 44197684)
21. LJ Donato JH Suh N Noy 2007 Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling Cancer Res 67 609 615 10.1158/0008-5472.CAN-06- 0989 10.1158/0008-5472.CAN-06-0989 1:CAS:528:DC%2BD2sXmtVKktA%3D%3D 17234770 (Pubitemid 46192199)
22. C Evangelisti A Astolfi GC Gaboardi P Tazzari A Pession K Goto AM Martelli 2009 TIS21/BTG2/PC3 and cyclin D1 are key determinants of nuclear diacylglycerol kinase-zeta-dependent cell cycle arrest Cell Signal 21 801 809 10.1016/j.cellsig.2009.01.027 10.1016/j.cellsig.2009.01.027 1:CAS:528: DC%2BD1MXisFWjsbg%3D 19263516
23. D Guardavaccaro G Corrente F Covone L Micheli I D'Agnano G Starace M Caruso F Tirone 2000 Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription Mol Cell Biol 20 1797 1815 10.1128/MCB.20.5.1797-1815.2000 10.1128/MCB.20.5.1797-1815. 2000 1:CAS:528:DC%2BD3cXhtF2ntLs%3D 10669755 (Pubitemid 30100197)
24. MS Ryu MS Lee JW Hong TR Hahn E Moon IK Lim 2004 TIS21/BTG2/PC3 is expressed through PKC-delta pathway and inhibits binding of cyclin B1-Cdc2 and its activity, independent of p53 expression Exp Cell Res 299 159 170 10.1016/j.yexcr.2004.05.014 10.1016/j.yexcr.2004.05.014 1:CAS:528: DC%2BD2cXmsVKgu78%3D 15302583 (Pubitemid 39078391)
25. F el-Ghissassi S Valsesia-Wittmann N Falette C Duriez PD Walden A Puisieux 2002 BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells Oncogene 21 6772 6778 10.1038/sj.onc.1205888 10.1038/sj.onc.1205888 1:CAS:528:DC%2BD38XntFentbs%3D 12360398